Pfizer CEO: COVID antiviral pill reduces hospitalization rates up to 89% in high-risk adults

Pfizer: Oral Covid antiviral cut risk of hospitalization, death by 89%Подробнее

Pfizer's Covid drug reduced hospitalization, death risk by 89% in final resultsПодробнее

Pfizer says COVID-19 antiviral pill 89% effective in high-risk casesПодробнее

Pfizer says COVID antiviral pill reduces risk of hospitalization and deathПодробнее

Pfizer Says Its Covid Pill Reduces Risk of Hospitalization, DeathПодробнее

New Pfizer COVID Antiviral Pill Cuts Hospital, Death Risk By 89%, Study ShowsПодробнее

Pfizer to submit Covid pill to FDA before Thanksgiving: CEOПодробнее

Pfizer Says Pill For COVID Reduces Risk Of Hospitalizations, DeathsПодробнее

New Trial Data Confirms High Efficacy Of COVID Antiviral PillsПодробнее

Pfizer: New antiviral pill for COVID cut hospital and death risk by 89%Подробнее

Pfizer says antiviral pill can cut risk of COVID-19 hospitalization by 89%Подробнее

Pfizer Says Its COVID Pill Is 89 Percent EffectiveПодробнее

Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%Подробнее

Pfizer says COVID-19 antiviral pill 89% effective in high-risk casesПодробнее

Pfizer says COVID-19 pill cut hospital, death risk by 90%Подробнее

Pfizer says pill cuts severe COVID risk by 89%Подробнее

Pfizer says COVID-19 pill cut hospital, death risk by nearly 90%Подробнее

Pfizer Says Its Covid Pill Reduced Risk Of Hospitalization And Death By 89% In Clinical StudyПодробнее

Pfizer Covid Pill Stops Hospitalization, Not Milder SymptomsПодробнее